# Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

> **NCT01063218** · PHASE4 · COMPLETED · sponsor: **Galderma Brasil Ltda.** · enrollment: 74 (estimated)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **OTHER:** Emollient - Cetaphil Advanced

## Key facts

- **NCT ID:** NCT01063218
- **Lead sponsor:** Galderma Brasil Ltda.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-10
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2012-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063218, "Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01063218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*